HOME >> BIOLOGY >> NEWS
Materials scientists get the whole picture with new e-Science technique

An output of the UK e-Science Programme is helping researchers to find needles of insight in the haystack of data generated by bigger and better facilities to probe matter with intense particle or X-ray beams. Dr Lakshmi Sastry will present the work at the e-Science All Hands meeting in Nottingham on Monday 19 September.

Dr Sastry and colleagues have developed new techniques to enable scientists to visualise data using distributed resources on a computing Grid. Dr Toby Perring is helping her to develop the techniques for users of the ISIS spallation neutron source at the CCLRC Rutherford Appleton Laboratory (RAL). "We've got really good instruments and need the software to exploit them to the full. The Grid will allow us to do this. All of us who run huge multi-detector instruments see this as the way forward," he says.

Two major new facilities are due to come on line at RAL over the next few years. The Diamond synchrotron X-ray source will start producing data on the crystal structure of many molecules, in particular those of biological significance, by the end of next year. Opportunities to study materials with neutron beams will more than double from 2008 when a second target station comes online at ISIS. Neutrons are especially useful for studying the position and motion of atoms within materials, which govern properties such as magnetism or high temperature superconductivity.

Dr Perring works with one of 19 ISIS instruments, MAPS, to study the motions of magnetic moments and atoms within materials. MAPS detectors take 30 minutes to two days to generate 10 million bits of data from one sample. This data needs to be visualised and compared, or fitted, with theoretical models if it is to be understood and interpreted correctly. "This is a sheer computing power problem. With a single processor we can't fit all our data to the models," says Dr Perring.

Dr Sastry has taken the data-ftting program Dr Perring was using on his des
'"/>

Contact: Judy Redfearn
judy.redfearn@epsrc.ac.uk
44-776-835-6309
Engineering and Physical Sciences Research Council
21-Sep-2005


Page: 1 2 3

Related biology news :

1. Nanostructured Materials: Environmental, Energy and Sensing Applications
2. UK scientists working to help cut ID theft
3. Smithsonian scientists show differing patterns of rainforest biodiversity
4. Weizmann Institute scientists discover a control mechanism for metastasis
5. Cornell scientists link E. coli bacteria to Crohns disease
6. UCLA scientists produce functioning neurons from human embryonic stem cells
7. ASBMB taps 8 scientists and 1 politician for top awards
8. UF, French scientists seek test to detect gene doping in athletes
9. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells
10. Forsyth scientists gain new understanding of adult stem cell regulation
11. Nanotechnology helps scientists make bendy sensors for hydrogen vehicles

Post Your Comments:
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "Global Facial Recognition ... http://photos.prnewswire.com/prnh/20130307/600769 ... identification of individuals. Facial recognition system measures the ... nose, jaw edges, mouth, and the distance between ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has ... in India 2015-2019" report to their offering. ... this market is the adoption of multimodal biometric ... characteristic of an individual for verification and identification ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/17/2014)... 2014 Ipsen Biopharmaceuticals, Inc., an ... IPSEY), today announced that Somatuline® Depot® ... was approved by the U.S. Food and Drug ... tumors (GEP-NETs) in adult patients with unresectable, well ... to improve progression-free survival (PFS). , “The approval ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... Calif. , Dec. 17, 2014 ... a Phase 2 study evaluating the investigational oral ... of patients with severe, chronic itch who are ... of care, including topical steroids and antihistamines. ... change in Visual Analog Scale (VAS) itch score ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: